${Monograph Name}

Subsidy Information and Financing Scheme

${Subsidy Information and Financing Scheme_1 - 15} - Split '~' [0], add more tags if applicable

Drug Guidance

${Drug Guidance for Subsidy_1 - 15} - Yes if exist, No if not

Post-marketing information

${Post-marketing Information_1} - Yes if exist, No if not

Summary of Biologics

${Monograph Name} - Yes if # is at the end of Monograph name

Active ingredients: ${Active Ingredient Group_1 - 15}

General information

Subsidy Information and Financing Scheme

[${Subsidy Information and Financing Scheme_1 - 15} - split '~' [0]] ${Subsidy Information and Financing Scheme_1 - 15} - split '|' [0]

${Subsidy Information and Financing Scheme_1 - 15} - remaining from ^, add hardBreak if
is present

Legend

This section shows the following:

Subsidy Scheme and Clinical Indication (where applicable) of drugs listed in the MOH List of Subsidised Drugs
Subsidised brands of vaccines recommended in the National Immunisation Schedules listed in the MOH Subsidised Vaccine List
Cancer Drug and Clinical Indication listed in the MediShield Life Cancer Drug List

As this website is updated monthly, please refer to MOH List of Subsidised Drugs, MOH Subsidised Vaccine List or MediShield Life Cancer Drug List for the most updated information.

Legend list

Indicator	Legend
SDL	Standard Drug List
MAF	Medical Assistance Fund
SVL	Subsidised Vaccine List
MSHL	Cancer Drug and Clinical Indication listed in the MediShield Life Cancer Drug List

Drug Guidance for Subsidy

${Drug Guidance for Subsidy_1 - 15}

${Guidance Recommendations_1 - 15}

General Availability in Public Healthcare Institution

Note:

General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.

Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration

Drug availability

Formulation	Public Healthcare Institution
${General Availability in Public Healthcare Institutions_1 - split '\|' [0]}	${General Availability in Public Healthcare Institutions_1 - remaining from split}
${General Availability in Public Healthcare Institutions_2 - 15 - split '\|' [0]}	${General Availability in Public Healthcare Institutions_2 - 15 - remaining from split}

List of monographs containing this active ingredient

${Monograph_Name - with other variations of the drug brands without the #}